Anti-p53 FITC
Isotype
Mouse IgG2a
Specificity
The antibody BP53-12 recognizes a defined epitope (aa 16-25) on human p53, a 50 kDa intracellular tumour suppressor found in increased amounts in a wide variety of transformed cells; it is frequently mutated or inactivated in many types of cancer.
Application
Application details
Flow cytometry: Recommended dilution: 3 μg/ml. Intracellular staining.
Reactivity
Human, Non-human primates
Immunogen
Bacterially expressed full-length wild-type p53
Concentration
1 mg/ml
Preparation
Purified antibody is conjugated with fluorescein isothiocyanate (FITC) under optimum conditions and unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.
Formulation
Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
Storage and handling
Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
Other names
BCC7, TRP53, TP53, LFS1
Antigen description
The tumour suppressor protein p53 is a key element of intracellular anticancer protection. It mediates cell cycle arrest or apoptosis in response to DNA damage or to starvation for pyrimidine nukleotides. It is up-regulated in response to these stress signals and stimulated to activate transcription of specific genes, resulting in expression of p21waf1 and other proteins involved in G1 or G2/M arrest, or proteins that trigger apoptosis, such as Bcl-2. The structure of p53 comprises N-terminal transactivation domain, central DNA-binding domain, oligomerisation domain, and C-terminal regulatory domain. There are various phosphorylation sites on p53, of which the phosphorylation at Ser15 is important for p53 activation and stabilization.
| Vendor | EXBIO Praha AS สาธารณรัฐเช็ก |
|---|
Related products
แอนติบอดี
แอนติบอดี
แอนติบอดี
แอนติบอดี
แอนติบอดี
แอนติบอดี
แอนติบอดี
แอนติบอดี